Herbas VPB

Print
EN | LT
LT - USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS
EN - USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4409
A61K 31/44
A61K 45/06
A61K 9/20
A61K 9/48
A01N 43/40
A61P 25/00
European patent
(11) Number of the document 2464229
(13) Kind of document T
(96) European patent application number 10808713.1
Date of filing the European patent application 2010-08-11
(97) Date of publication of the European application 2012-06-20
(45) Date of publication and mention of the grant of the patent 2015-11-25
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2010/045211
Date 2010-08-11
PCT application publication
(87) Number WO 2011/019845
Date 2011-02-17
Priority applications
(30) Number Date Country code
233077 P 2009-08-11 US
233069 P 2009-08-11 US
239877 P 2009-09-04 US
Inventors
(72)
WESSEL, Thomas, C., US
BLIGHT, Andrew, US
Grantee
(73) Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY 10502, US
Title
(54) USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS
  USE OF 4-AMINOPYRIDINE TO IMPROVE NEURO-COGNITIVE AND/OR NEURO-PSYCHIATRIC IMPAIRMENT IN PATIENTS WITH MULTIPLE SCLEROSIS
Last update date 2021-04-30